Gilead shares drop 4% after failure of NASH drug to meet primary endpoint
February 12, 2019Manufacturing and Production Gilead, Shares, fatty liver disease, nash, selonsertib
Gilead’s treatment for the progressive fatty liver disease, NASH, has failed to meet its primary goal in a phase 3 …
Solving the drug development problem
February 11, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, drug discovery, feature, pharma, pistoia alliance
Excitement is building for the potential of AI in just about every field, but how can it address pharma’s unique …
Vertex doubles Q4 profits, angering cystic fibrosis drug advocates in UK
February 11, 2019Sales and Marketing Orkambi, Vertex, cystic fibrosis, pharma
Despite ongoing controversy surrounding the currently stalled negotiations between Vertex and the NHS to make its cystic fibrosis (CF) drug …
Scientists identify alcoholism gene
February 11, 2019Research and Development, Sales and Marketing Alcohol misuse, alcoholism, ethanol, oregon, research
Scientists at the Oregon Health & Science University (OSHU) in Portland have identified a gene which may play a fundamental …
UCB teams up with charity to beat treatment-resistant epilepsy in $2.5m partnership
February 11, 2019Research and Development, Sales and Marketing Epilepsy Society, UCB Pharma, epilepsy, pharma
Belgian firm UCB Pharma has announced a new partnership with the charity Epilepsy Society which will see the pair invest …
Diet drugs supress appetite in mosquitoes, study shows
February 11, 2019Sales and Marketing Zika, dengue, infectuous diseases, malaria, mosquitoes
Scientists were able to supress mosquitoes appetites using diet drugs for humans, according to research published in the journal Cell. …
33% of antibiotics prescribed by NHS are given without associated diagnosis, England’s Chief Medical Officer warns
February 11, 2019Sales and Marketing AMR, Antibiotics, Dame Sally Davies, England, UK, pharma
A third of the antibiotics prescribed by the NHS are given out despite there being no medical evidence that they …
Dame Sally Davis to step down as England’s CMO to become Master of Trinity College, Cambridge
February 8, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Professor Dame Sally Davies is set to step down from her roles as England’s Chief Medical Officer and as the …
Researchers develop new, more effective method for detection of HIV virus genomes
February 8, 2019Medical Communications, Research and Development HIV, University of Texas, pharma
A team of researchers have devised a new way to accurately detect residual HIV in the body’s immune cells, allowing …
Pat Smallcombe appointed chairman of J&J Consumer, EMEA
February 8, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Johnson & Johnson Consumer has appointed Pat Smallcombe to the position of Company Group Chairman, Europe, Middle East, Africa (EMEA). …
FDA warns over breast implant cancer risk after nine deaths confirmed
February 8, 2019Medical Communications, Research and Development Cancer, FDA, breast implants, pharma
The FDA has warned against the link between breast implants and anaplastic large cell lymphoma, noting that at least nine …
Top Ten most popular articles on Pharmafile.com this week!
February 8, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, GSK, Merck, Pfizer, falsified medicines, strike, top 10
The strike in Ireland featured twice in this week’s top 10 after Pfizer employees in County Cork lost a dispute …
FMD would not apply in case of no-deal Brexit
February 8, 2019Medical Communications EU, FMD, UK, brexit, falsified medicines
The Falsified Medicines Directive would be scrapped in the event of a no deal Brexit, the Association of the British …
J&J to include prices in drug ads on TV
February 8, 2019Medical Communications J&J, JJ, Johnson & Johnson, Trump, pharma, pricing
US multinational Johnson & Johnson has announced that it will include the price of its medicines in TV commercials for …
Hansa Biopharma names Donato Spota as new CFO
February 7, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Swedish firm Hansa Biopharma has appointed Donato Spota as the company’s new Chief Financial Officer (CFO). Spota will succeed current …
Chimerix CEO M. Michelle Berrey to stand down as interim Office of Cheif Executive Officer is formed
February 7, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
The North Carolina-based biopharmaceutical company Chimerex has announced that Dr M. Michelle Berrey has resigned from her role as President …
Eisai and Purdue reveal positive Phase 3 data in insomnia
February 7, 2019Research and Development Eisai, Purdue Pharma, insomnia, lemborexant, pharma
Partners Eisai and Purdue Pharma have lifted the curtain on Phase 3 clinical data on their jointly developed therapy lemborexant …
Pharma chiefs will testify at Senate hearing on rising drug prices
February 7, 2019Sales and Marketing CEO, J&J, JJ, Pfizer, Sanofi, Senate, pharma, pricing
The Chief Executives of Pfizer, Sanofi and Bristol-Myers Squibb have said that they will join four other pharma execs in …
FDA approves first therapy for acquired thrombotic thrombocytopenic purpura: Sanofi’s Cablivi
February 7, 2019Sales and Marketing Calblivi, FDA, Sanofi, acquired thrombotic thrombocytopenic purpura, pharma
Following swiftly on the heels of the previous success with the announcement of positive Phase 3 data for Icaria in …
HIV drug holds hope for Alzheimer’s after significantly reducing inflammation in mice
February 7, 2019Research and Development HIV, dementia, inflamation
Lamivudine, a generic drug for HIV, significantly reduces age-related inflammation and other signs of aging in mice, according to a …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
